Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe.
about
Long term cardiac follow up of severe twin to twin transfusion syndrome after intrauterine laser coagulation.Intertwin cardiac status at 10-year follow-up after intrauterine laser coagulation therapy of severe twin-twin transfusion syndrome: comparison of donor, recipient and normal values.Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon.Clinical outcome of acute myocarditis in children according to treatment modalitiesOutcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany.NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivorsPeripheral microvascular function is altered in young individuals at risk for hypertrophic cardiomyopathy and correlates with myocardial diastolic function.Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial.Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment.Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)Regression equations for calculation of z scores for echocardiographic measurements of right heart structures in healthy Han Chinese children.A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.The relationship between biventricular myocardial performance and metabolic parameters during incremental exercise and recovery in healthy adolescents.Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney DiseaseCardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infectionEnzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapyMucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.Six-Minute Walking Test: Normal Reference Values for Taiwanese Children and AdolescentsBurn-induced cardiac dysfunction increases length of stay in pediatric burn patients.Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain.Single-ventricle anatomy predicts delayed microstructural brain developmentLong-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case seriesEffects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center studySystemic hypertension requiring treatment in the neonatal intensive care unitEchocardiographic and electrocardiographic trends in children with acute Kawasaki disease.Predictors of Mortality in Paediatric Myocarditis.Reference intervals for the echocardiographic measurements of the right heart in children and adolescents: a systematic review.Quantification of myocardial deformation in children by cardiovascular magnetic resonance feature tracking: determination of reference values for left ventricular strain and strain rate.Comparison of echocardiography with tissue Doppler imaging and magnetic resonance imaging with delayed enhancement in the assessment of children with hypertrophic cardiomyopathy.Optimal normative pediatric cardiac structure dimensions for clinical use.Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy.Echocardiographic reference ranges in older children and adolescents in sub-Saharan Africa.The Mystery of the Z-Score.Restrictive right ventricular performance assessed by cardiac magnetic resonance after balloon valvuloplasty of critical pulmonary valve stenosis.N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study.Clinical and functional characterisation of rheumatic mitral regurgitation in children and adolescents including the brain natriuretic peptide.Coronary Artery Dilatation in Viral Myocarditis Mimics Coronary Artery Findings in Kawasaki Disease.Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program.
P2860
Q31158146-1EEDB0DB-8268-4757-A7E0-05CB7287CE10Q31168661-A558F5D6-8308-4B5B-8509-851BF6576487Q33587493-E73A48B1-D49D-4B60-A44B-2E94EAE190BEQ34417337-2C6032C3-8CCF-4FFB-9DFA-18E6BDE8424BQ35220683-EC1E264F-D9F6-4F35-83A2-9790B194F817Q35557142-F7EC950C-7449-45A7-AC3B-52E65CA3AD71Q35583070-9DC5E51C-CE1E-4875-A8F6-679A0489012CQ35587768-5D5FD5D3-9FEF-4C96-A177-52DACB592DEEQ36105190-C8CD4583-3205-4CAB-B617-DB944E7D2FC2Q36127763-93C8F85C-B60B-4AA1-94E8-F0AFA4EBB60DQ36259472-8EB3CFC9-282D-4825-A1E2-13E12354A64CQ36342315-91052922-646B-43D4-9F8E-F2AAC7741A93Q36422615-FF72DD86-82D0-4482-9002-8C64EDBF13B7Q36538869-07CBA9FB-CD28-48CF-973B-634F22D7E165Q36555275-A3D891DC-1387-41AB-9AD8-6F2A0EEC64A3Q36662791-6E26BFDC-FC37-4C7D-800A-757C8B900186Q36662835-637893AC-33E5-4890-BC4C-5AC31A3E2DDAQ36721854-AD5A5EE8-8B1F-42CC-BF50-02ECE10E93E1Q36724666-607C296F-675E-4284-A727-19BC5A6142E7Q36762345-71C92F82-294C-4068-AE00-D0122D084323Q36767452-97B60E83-E4E9-4FA1-B1A3-FD606E93F7CDQ36780828-87B61F38-9D51-43A1-8879-F6EBF8FF1A6DQ36806851-BC6F13E4-EF64-47E5-B935-AE1676BDA160Q36853458-864754FD-E7BA-4DAD-B8C9-DFBE5FAE41CEQ36909140-C069A845-4C0B-4153-B15D-765DFB5E5803Q37098307-22B0A715-85D8-473D-AC55-66C83248F521Q37132700-46732322-2C68-415E-9462-EAAEE6BAE252Q37580808-9EBCAA37-674E-431A-95A3-5F3AED61B2DCQ37595670-1FCE1965-A50B-4B1C-884B-A1B0F74569E9Q37675552-9445C24F-98F3-45C6-9411-0CCDC60CB019Q38117353-5EEBBC42-EF2D-4772-9B90-67668E32E9D3Q38615407-E73C6EA4-4514-4814-AE6C-EA6C8474B5DEQ38677607-62BC5DDB-75F7-407B-97D2-2C217BA18083Q39093023-840B82C5-3A4A-4768-A4CE-C326D48008DAQ39187569-056620E5-7295-489B-B714-BE77C65165F1Q40176185-5E53A677-1369-4983-AD42-8555DFFC33F9Q40183631-09EE8402-3C2A-4153-87DB-807A7EF31ABAQ40365615-05D09C38-C713-433C-8548-2B8B1351A60DQ40732093-7F49F08B-1197-4622-AD69-AD52E71DB795Q41067602-73669650-D4EB-4BBE-8866-00D61011EFEA
P2860
Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Normal values of M mode echoca ...... nd children in central Europe.
@en
Normal values of M mode echoca ...... nd children in central Europe.
@nl
type
label
Normal values of M mode echoca ...... nd children in central Europe.
@en
Normal values of M mode echoca ...... nd children in central Europe.
@nl
prefLabel
Normal values of M mode echoca ...... nd children in central Europe.
@en
Normal values of M mode echoca ...... nd children in central Europe.
@nl
P2093
P2860
P356
P1433
P1476
Normal values of M mode echoca ...... nd children in central Europe.
@en
P2093
Betancor M
Emschermann T
Habermehl P
Kampmann C
Stopfkuchen H
Wiethoff CM
P2860
P304
P356
10.1136/HEART.83.6.667
P407
P577
2000-06-01T00:00:00Z